During the past decade, Research Institute of Influenza conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 8 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Research Institute of Influenza" #1 sponsor was "Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation" with 4 trials, followed by "PATH" with 4 trials sponsored, "PHARMENTERPRISES LLC" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Institute of Influenza" #1 collaborator was "Institute of Experimental Medicine, Russia" with 4 trials as a collaborator, "Ministry of Health, Russian Federation" with 2 trials as a collaborator, "Research Institute of Influenza, Russia" with 2 trials as a collaborator, "Research Institute of Influenza, Sankt-Peterburg, Russian Federation" with 2 trials as a collaborator and "Microgen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Research Institute of Influenza" are "Influenza" (7 trials), "Acute Respiratory Infection" (2 trials), "Acute Respiratory Viral Infections" (2 trials), "HBV" (2 trials) and "Avian Influenza" (1 trials). Many other conditions were trialed in "Research Institute of Influenza" in a lesser frequency.

Most popular intervention types in "Research Institute of Influenza" are "Biological" (9 trials), "Drug" (9 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "TAF" (2 trials), "TAF Placebo" (2 trials), "TDF" (2 trials) and "TDF Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Research Institute of Influenza" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Research Institute of Influenza". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Research Institute of Influenza, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Research Institute of Influenza, 8 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".